QIAGEN N.V. today announced the 2,000th placement of QIAsymphony, the leading Sample to Insight workflow automation solution for molecular laboratories worldwide.
Outstanding and unmatched capabilities fuel strong growth in installed base and consumables use on highly versatile Sample to Insight automation solution |
| [13-November-2017] |
|
HILDEN, Germany and GERMANTOWN, Maryland, November 13, 2017 /PRNewswire/ -- QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced the 2,000th placement of QIAsymphony, the leading Sample to Insight workflow automation solution for molecular laboratories worldwide. The milestone means QIAGEN has already exceeded its year-end 2017 goal of exceeding 2,000 cumulative placements. The rapid dissemination of QIAsymphony systems, as well as the increasing menu and new capabilities, are fueling double-digit growth in sales of the systems' related consumables. Click here [https://corporate.qiagen.com/newsroom/press-releases/2017/2017-11-13-QIAsymphony?sc_lang=en ] for the full press release https://corporate.qiagen.com/newsroom/press-releases/2017/2017-11-13-QIAsymphony?sc_lang=en Contacts: QIAGEN
Investor Relations
John Gilardi
+49-2103-29-11711
e-mail: ir@QIAGEN.com
Public Relations
Dr. Thomas Theuringer
+49-2103-29-11826
e-mail: pr@QIAGEN.com
SOURCE QIAGEN N.V. |
||
Company Codes: Frankfurt:QIA, NASDAQ-NMS:QGEN, Bloomberg:QGEN@US, Bloomberg:QIA@GR, RICS:QGEN.F, ISIN:NL0000240000 |
